Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section wording was updated to indicate PubMed auto-fill and that some articles may not be about the study, with the revision version updated to v3.3.2; The previous PubMed-originated publication wording and the older revision note (v3.2.0) were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedMinor metadata updates (Last Update Posted date) with no changes to core content such as eligibility criteria, primary/secondary outcomes, or study design. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedAdded updated contact details (phone and email) and a new Revision tag (v3.1.0) while removing the old Revision tag (v3.0.2).SummaryDifference0.1%

- Check84 days agoChange DetectedVersion upgraded from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.